Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Glucocorticoid-targeted therapies for the treatment of rheumatoid arthritis.

Strehl C, van der Goes MC, Bijlsma JW, Jacobs JW, Buttgereit F.

Expert Opin Investig Drugs. 2017 Feb;26(2):187-195. doi: 10.1080/13543784.2017.1276562. Epub 2017 Jan 3. Review.

PMID:
28043173
2.

Can adverse effects of glucocorticoid therapy be prevented and treated?

van der Goes MC, Strehl C, Buttgereit F, Bijlsma JW, Jacobs JW.

Expert Opin Pharmacother. 2016 Nov;17(16):2129-2133. Epub 2016 Sep 20. No abstract available.

PMID:
27590884
3.

Rediscovering the therapeutic use of glucocorticoids in rheumatoid arthritis.

van der Goes MC, Jacobs JW, Bijlsma JW.

Curr Opin Rheumatol. 2016 May;28(3):289-96. doi: 10.1097/BOR.0000000000000278. Review.

PMID:
26962704
4.

Alternative Ways to Quantify Sustained Remission: Applying the Continuity Rewarded Score and Patient Vector Graph.

Jurgens MS, Jacobs JW, Boers M, van der Goes MC, van der Veen MJ, Lafeber FP, Bijlsma JW; Utrecht Arthritis Cohort study group.

Arthritis Care Res (Hoboken). 2015 Oct;67(10):1471-4. doi: 10.1002/acr.22565.

5.

The value of glucocorticoid co-therapy in different rheumatic diseases--positive and adverse effects.

van der Goes MC, Jacobs JW, Bijlsma JW.

Arthritis Res Ther. 2014 Nov 13;16 Suppl 2:S2. doi: 10.1186/ar4686. Review.

6.

Identifying factors hampering physical activity in longstanding rheumatoid arthritis: what is the role of glucocorticoid therapy?

van der Goes MC, Hoes JN, Cramer MJ, van der Veen MJ, van der Werf JH, Bijlsma JW, Jacobs JW.

Clin Exp Rheumatol. 2014 Mar-Apr;32(2):155-61. Epub 2014 Jan 24.

PMID:
24480192
7.

Glucocorticoids in systemic sclerosis: weighing the benefits and risks - a systematic review.

Iudici M, van der Goes MC, Valentini G, Bijlsma JW.

Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):157-65. Epub 2013 Jul 23. Review.

PMID:
23910618
8.

EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases.

Duru N, van der Goes MC, Jacobs JW, Andrews T, Boers M, Buttgereit F, Caeyers N, Cutolo M, Halliday S, Da Silva JA, Kirwan JR, Ray D, Rovensky J, Severijns G, Westhovens R, Bijlsma JW.

Ann Rheum Dis. 2013 Dec;72(12):1905-13. doi: 10.1136/annrheumdis-2013-203249. Epub 2013 Jul 19.

9.

Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?

van der Goes MC, Jacobs JW, Jurgens MS, Bakker MF, van der Veen MJ, van der Werf JH, Welsing PM, Bijlsma JW.

Osteoporos Int. 2013 Apr;24(4):1429-36. doi: 10.1007/s00198-012-2073-z. Epub 2012 Aug 2.

10.

Intra-articular glucocorticoid injections decrease the number of steroid hormone receptor positive cells in synovial tissue of patients with persistent knee arthritis.

van der Goes MC, Straub RH, Wenting MJ, Capellino S, Jacobs JW, Jahangier ZN, Rauch L, Bijlsma JW, Lafeber FP.

Ann Rheum Dis. 2012 Sep;71(9):1552-8. doi: 10.1136/annrheumdis-2011-201019. Epub 2012 Apr 13.

PMID:
22504564
11.

Glucocorticoids.

Spies CM, Strehl C, van der Goes MC, Bijlsma JW, Buttgereit F.

Best Pract Res Clin Rheumatol. 2011 Dec;25(6):891-900. doi: 10.1016/j.berh.2011.11.002. Review.

PMID:
22265268
12.

Toward safer treatment with glucocorticoids: via patient and rheumatologist perspectives to recommendations on monitoring for adverse events.

van der Goes MC, Jacobs JW, Bijlsma JW.

Clin Exp Rheumatol. 2011 Sep-Oct;29(5 Suppl 68):S116-20. Epub 2011 Oct 22.

PMID:
22018196
13.

Glucose tolerance, insulin sensitivity and β-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids.

Hoes JN, van der Goes MC, van Raalte DH, van der Zijl NJ, den Uyl D, Lems WF, Lafeber FP, Jacobs JW, Welsing PM, Diamant M, Bijlsma JW.

Ann Rheum Dis. 2011 Nov;70(11):1887-94. doi: 10.1136/ard.2011.151464. Epub 2011 Sep 10.

PMID:
21908880
14.

Changes in macrophage inhibitory factor correlate with changes in bone mineral density in glucocorticoid-treated patients with rheumatoid arthritis.

Hoes JN, Van der Goes MC, Jacobs JW, Lafeber FP, Bijlsma JW, Van Roon JA.

Rheumatology (Oxford). 2011 Oct;50(10):1921-4. doi: 10.1093/rheumatology/ker268. Epub 2011 Aug 18.

PMID:
21852299
15.

Cortisol during the day in patients with systemic lupus erythematosus or primary Sjogren's syndrome.

van der Goes MC, Bossema ER, Hartkamp A, Godaert GL, Jacobs JW, Kruize AA, Derksen RH, Bijlsma JW, Geenen R.

J Rheumatol. 2011 Feb;38(2):285-8. doi: 10.3899/jrheum.100572. Epub 2010 Dec 15.

PMID:
21159832
16.

Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice.

van der Goes MC, Jacobs JW, Boers M, Andrews T, Blom-Bakkers MA, Buttgereit F, Caeyers N, Cutolo M, Da Silva JA, Guillevin L, Kirwan JR, Rovensky J, Severijns G, Webber S, Westhovens R, Bijlsma JW.

Ann Rheum Dis. 2010 Nov;69(11):1913-9. doi: 10.1136/ard.2009.124958. Epub 2010 Aug 6.

PMID:
20693273
17.

Low-dose glucocorticoid therapy in rheumatoid arthritis: an obligatory therapy.

Bijlsma JW, van der Goes MC, Hoes JN, Jacobs JW, Buttgereit F, Kirwan J.

Ann N Y Acad Sci. 2010 Apr;1193:123-6. doi: 10.1111/j.1749-6632.2009.05342.x. Review.

PMID:
20398017
18.

Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.

van der Goes MC, Jacobs JW, Boers M, Andrews T, Blom-Bakkers MA, Buttgereit F, Caeyers N, Choy EH, Cutolo M, Da Silva JA, Guillevin L, Holland M, Kirwan JR, Rovensky J, Saag KG, Severijns G, Webber S, Westhovens R, Bijlsma JW.

Ann Rheum Dis. 2010 Jun;69(6):1015-21. doi: 10.1136/ard.2009.114579. Epub 2009 Sep 17.

PMID:
19762359
19.

The Olmsted syndrome.

Santos OL, Amorim JH, Voloch K, Gomes M, Ramos-e-Silva M, Pereira Júnior AC.

Int J Dermatol. 1997 May;36(5):359-60. No abstract available. Erratum in: Int J Dermatol. 2003 Sep;42(9):760. Silva, MR [corrected to Ramos-e-Silva, M]; Goes, MC [corrected to Gomes, M].

PMID:
9199984

Supplemental Content

Support Center